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INTRODUCTION:  Ultrasound  sonography  (US)-guided  navigation  systems  are  widely  used in various
organs,  including  the  breast  and  liver,  to locate  precisely  lesions  that  are  difﬁcult  to  palpate  or  isolate
after  being  identiﬁed  by other  imaging  techniques.  A  recent  new  method,  “volume  navigation”  (Vnav),
delivers  real-time  image  fusion  of  US  with  other  modalities  such  as MRI,  CT, and  PET/CT  to facilitate
identiﬁcation  and excision  of  suspected  pathology.
PRESENTATION OF  CASE:  The  present  report  describes  a novel  navigation  technique  using  Vnav-PET/CT,
which  delivers  image  fusion  of  US  with  PET/CT.  To  identify  the  axillary  targets  using  Vnav-PET/CT,  we  set
at  least  two  landmarks  then  injected  0.2  ml  viscous  blue  dye  in  and around  the capsule,  which  resulted
in  precise  resection.  Case  1: A  53-year-old  woman  with  2  PET/CT-positive  lymph  nodes  in the right  axilla
underwent  easy  identiﬁcation  of the  targets  using  the  navigation  technique  followed  by lymph  node
dissection.  Among  32  lymph  nodes  dissected,  only  the  two  lymph  nodes  stained  by blue dye  were  shown
histologically  to be  malignant.  Case  2: A  68-year-old  woman  had  a PET/CT-positive  lymph  node  in the  left
axilla.  Vnav-PET/CT  easily  identiﬁed  the  target,  which  was  successfully  dissected  under  local  anaesthesia.
DISCUSSION:  This  navigation  and  marking  using  Vnav-PET/CT  helped  us easily  approach  the  target,
resulted  in  less  surgical  time,  and  avoided  unsatisfactory  axillary  complications.  These  advances  of  the
navigation  system  enable  us  to  perform  precise  minimally  invasive  surgery.
CONCLUSION: This  is the  ﬁrst  report  of  navigation  surgery  using  Vnav-PET/CT,  which  may  assist  minimally
invasive  procedures,  especially  in  the  axilla.
© 2013 Surgical Associates Ltd. Published by Elsevier Ltd.   Open access under CC BY-NC-ND license. . Introduction
Navigation systems have been widely adopted in various ﬁelds
or diagnostic and therapeutic interventions. Even in the surgical
eld, this method may  provide precise anatomical information and
ermit minimally invasive surgery. Ultrasound sonography (US)
uidance is essential for breast surgery, but a lesion of less than
 cm in size may  be difﬁcult to identify, resulting in misdiagno-
is. To overcome this problem, new technologies such as volume
avigation (Vnav) or real-time virtual sonography (RVS) have been
eveloped. These systems yield real-time image fusion of US with
ther modalities such as MRI  or CT for identifying breast masses.1,2e  are interested in the application of real-time fusion of US with
DG-PET/CT in the surgical ﬁeld. In this paper, we report the ﬁrst
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Open access under CC BY-experiences of navigation using US fused with PET/CT, called Vnav-
PET/CT, in 2 cases of axillary neoplasm.
2. Presentation of cases
Method:  The navigation technique was performed using a sys-
tem conﬁgured with volume navigation equipment (LOGIQ E9; GE
Healthcare, Milwaukee, WI,  USA) in the operation room. To co-
register the US image with that of the PET/CT dataset, at least two
landmarks (e.g., nipple, pectoral muscle edge, the rib, etc.) were
manually identiﬁed on the US image and the PET/CT dataset. A
transformation matrix was used to display the multiplanar recon-
structed (MPR) image from the PET/CT dataset corresponding to the
live US image in the supine position. As the US image was moved,
the MPR-PET/CT image tracked the movement in real time. Both
US and PET/CT images were displayed side-by-side and activated
alternately during the procedure, which enabled easy identiﬁcation
of the PET/CT-positive object before surgery. After we identiﬁed the
target, we  injected 0.2 ml  blue dye gel (indigocarmine or indocyanin
green (ICG) mixed with a similar quantity of lidocaine jelly) in and
NC-ND license. 
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Fig. 1. Navigation surgery using Vnav-PET/CT. (A) Navigation was  performed in the operation room before surgery using LOGIC E9. (B) Blue dye gel was  injected using
real-time US guidance.
Fig. 2. Presentation of Case 1. (A) Coronal PET/CT view. Two  positive lymph nodes were detected in the right axilla. (B) Fusion image of real-time US (left) and PET/CT (right)
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Pf  the rostral large lymph node. Ly and arrow indicate the target lymph node. (C) I
mall target. (E) Injection of blue dye. (F) Operative ﬁndings. Two blue spots were e
ymph nodes were indicated by arrows. (For interpretation of the references to colo
round the capsule of the lymph node using real-time US guidance
Fig. 1A and B). The aim of this method was explained and informed
onsent was obtained from each patient prior to surgery. This study
as approved by the institutional Ethical Committee.
Case 1: In December 2011, a 53-year-old woman presented with
ET/CT-positive (SUVmax: 10.89) right axillary masses (16 mm in
ize with an SUVmax of 9.28, 10 mm with 3.94) (Fig. 2A). At surgery
nder general anaesthesia, the targets were detected using Vnav-
ET/CT followed by viscous blue dye injection through a 23-G ﬁne
eedle under US guidance (Fig. 2B–E). During surgery, 2 blue spots
ere readily identiﬁed and completely removed during axillary
ymph node dissection (ALND). Among 32 lymph nodes dissected,
he 2 marked lymph nodes were histologically diagnosed as ﬁbro-
lastic reticular cell tumour, a form of lymph node neoplasma.3 No
ther lymph nodes were involved (Fig. 2F and G).
Case 2: In September 2012, a 68-year-old woman presented
ith a 16-mm axillary mass with a high SUVmax (6.15) on
ET/CT (Fig. 3A). Vnav-PET/CT was performed followed by blue dyen of blue dye. The arrow indicates the ﬁne needle. (D) Fusion image of the caudal
identiﬁed and dissected. (G) Mapping of dissected lymph nodes. Two blue-stained
is ﬁgure legend, the reader is referred to the web version of the article.)
injection in the target lymph node (Fig. 3B and C). The target lymph
node was easily removed under local anaesthesia and was diag-
nosed as B-cell lymphoma (Fig. 3D).
Mammography, US, and MRI  revealed no evidence of breast can-
cer in these cases.
3.  Discussion
Sentinel lymph node biopsy (SLNB) is superior to ALND for axil-
lary evaluation in early breast cancer patients.4 In accordance with
minimally invasive surgery, SLNB should be carefully performed to
prevent unfavourable complications such as lymphedema of the
upper limb. Various methods have been employed to identify the
SLN such as use of blue dye or radioisotopes (RIs), and ﬂuorescence
imaging (FI) using ICG or computed tomography lymphoscintigra-
phy (CT-LG), indicating that navigation is critical in SLNB.5–7 These
methods greatly assist SLNB, but the target may  be missed because
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Fig. 3. Presentation of Case 2. (A) Coronal PET/CT view. One positive lymph node was detected in the left axilla. (B) Fusion image of real-time US (left) and PET/CT (right). (C)
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Cnjection  of blue dye. The arrow indicates the ﬁne needle. (D) Operative ﬁndings. Th
he  references to color in this ﬁgure legend, the reader is referred to the web versio
f a fatty axilla or disruption of afferent lymphatic vessels. Even
f we recognise the target on US, more time may  be required to
dentify it during surgery. Thus, we described a combination of
nav and PET/CT as navigation for axillary surgery. This navigation
nd marking helped us easily approach the target even under local
naesthesia, resulted in less surgical time, and avoided unsatisfac-
ory axillary complications. The target lymph nodes ranged from 10
o 16 mm in our cases, but we believe this method would be suitable
or lesions more than 5 mm in size as long as they are detectable by
S. As is frequently used in partial mastectomy, the injection of vis-
ous blue dye allows easy identiﬁcation of the target during surgery
ecause the dye does not disperse to the surrounding tissue.
These  advanced features of the navigation system enable us
o perform precise minimally invasive surgery. However, PET/CT
ay not be useful in micrometastatic lymph nodes due to low
ensitivity,8 and SLNB is indicated in patients with clinically node-
egative breast cancer. On the other hand, clinical data from Z0011
rial would suggest the possibility of omitting ALND, even in cases
ith micrometastasis.9 Z0011 is a phase 3 non-inferiority trial
hat compares women with invasive breast cancer and sentinel
ode metastasis who underwent ALND with those who did not
ndergo ALND. Thus, non-surgical approaches, such as needle/core
iopsy proposed by Sever et al. may  also be feasible for preoper-
tive axillary evaluation.10 Therefore, our system can be used as
 useful navigation technique for appropriate SLNB if these prob-
ems are resolved. Further modiﬁcations and investigations are
equired.
. Conclusion
We  applied a novel navigation technique using Vnav-PET/CT.
his US image fusion technique may  facilitate minimally invasive
urgery, especially in the axilla.onﬂict of interest statement
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e article.)
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